NASDAQ · Biotechnology

MiMedx Group, Inc (MDXG) Stock

$4.67 +1.08% NASDAQ: MDXG Healthcare

Valuation

MetricValue
Price$4.67
Market Cap$680.70M
P/E Ratio115.74
P/B Ratio3.17
P/S Ratio1.90
EPS (TTM)$0.32
52-Week High$7.97
52-Week Low$3.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE2.61%
ROA2.22%
ROCE3.61%
Gross Margin81.04%
Operating Margin10.17%
Net Margin1.76%
Debt/Equity0.01
Current Ratio4.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$242.0M$268.0M$321.0M$349.0M$419.0M
Operating Profit$-7.0M$-15.0M$37.0M$59.0M$64.0M
Net Profit$-12.0M$-30.0M$67.0M$42.0M$49.0M
EPS$-0.09$-0.27$0.38$0.28$0.32
Op Margin-2.9%-5.5%11.6%16.9%15.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$188.0M$171.0M$239.0M$264.0M$343.0M
Total Liabilities$95.0M$97.0M$96.0M$71.0M$86.0M
Cash$87.0M$66.0M$82.0M$104.0M$166.0M
Borrowings$53.0M$52.0M$48.0M$25.0M$23.0M

Latest News

MiMedx Group (MDXG) Stock Faces Mixed Analyst Target Changes After Guidance Cut Simply Wall St. · Jun 20, 2026 How The MiMedx Group (MDXG) Story Is Shifting As Analysts Rework Price Targets Simply Wall St. · Jun 6, 2026 MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference GlobeNewswire · May 21, 2026 Is the Options Market Predicting a Spike in MiMedx Group Stock? Zacks · May 11, 2026 MiMedx Launches G4Derm Plus Wound-Care Product Across US MT Newswires · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-18.0M$27.0M$66.0M$74.0M
Investing Cash Flow$-7.0M$-4.0M$-4.0M$-11.0M$-8.0M
Financing Cash Flow$-5.0M$-1.0M$-10.0M$-4.0M$-4.0M
Net Cash Flow$-9.0M$-21.0M$16.0M$22.0M$62.0M
Free Cash Flow$-5.0M$-19.0M$25.0M$65.0M$73.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.41
EV / EBITDA22.81
FCF Yield6.01%
Quick Ratio4.79
Interest Coverage5.50
Return 1Y-40.40%
Return 3Y-44.64%
Return 5Y-63.06%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSEMBioStem Technologies, Inc. $2.47 -6.44% -1.66 $41.95M 0.00%
CELUCelularity Inc. $1.56 +6.85% -0.51 $45.16M 0.00%
LCTXLineage Cell Therapeutics, Inc. $0.99 -3.50% -6.61 $247.80M 0.00%
MDWDMediWound Ltd. $12.54 +0.97% -8.45 $161.09M 0.00%
ORGOOrganogenesis Holdings Inc. - Class A $1.29 +0.78% -1.62 $165.99M 0.00%

About MiMedx Group, Inc

MiMedx Group, Inc is led by CEO Joseph H. Capper, employs 837 people, headquartered in US, publicly traded since 2008.

MiMedx Group, Inc (MDXG) stock trades at $4.67 with a market capitalization of $680.70M. The stock is valued at a price-to-earnings (P/E) ratio of 115.74, price-to-book of 3.17, price-to-sales of 1.90. Over the past 52 weeks the stock has ranged between $3.03 and $7.97, and currently trades 41.4% below its 52-week high.

On profitability, MiMedx Group, Inc generates a return on equity (ROE) of 2.61%, return on capital employed of 3.61%, an operating margin of 10.17%, a net profit margin of 1.76%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides